Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.

Abstract:

:Although preclinical work with rapalogs suggests potential in treatment of multiple myeloma (MM), they have been less successful clinically. These drugs allostearically inhibit the mammalian target of rapamycin kinase primarily curtailing activity of the target of rapamycin complex (TORC)1. To assess if the mammalian target of rapamycin within the TORC2 complex could be a better target in MM, we tested a new agent, pp242, which prevents activation of TORC2 as well as TORC1. Although comparable to rapamycin against phosphorylation of the TORC1 substrates p70S6kinase and 4E-BP-1, pp242 could also inhibit phosphorylation of AKT on serine 473, a TORC2 substrate, while rapamycin was ineffective. pp242 was also more effective than rapamycin in achieving cytoreduction and apoptosis in MM cells. In addition, pp242 was an effective agent against primary MM cells in vitro and growth of 8226 cells in mice. Knockdown of the TORC2 complex protein, rictor, was deleterious to MM cells further supporting TORC2 as the critical target for pp242. TORC2 activation was frequently identified in primary specimens by immunostaining for AKT phosphorylation on serine 473. Potential mechanisms of up-regulated TORC2 activity in MM were stimulation with interleukin-6 or insulin-like growth factor 1, and phosphatase and tensin homolog or RAS alterations. Combining pp242 with bortezomib led to synergistic anti-MM effects. These results support TORC2 as a therapeutic target in MM.

journal_name

Blood

journal_title

Blood

authors

Hoang B,Frost P,Shi Y,Belanger E,Benavides A,Pezeshkpour G,Cappia S,Guglielmelli T,Gera J,Lichtenstein A

doi

10.1182/blood-2010-05-285726

subject

Has Abstract

pub_date

2010-11-25 00:00:00

pages

4560-8

issue

22

eissn

0006-4971

issn

1528-0020

pii

blood-2010-05-285726

journal_volume

116

pub_type

杂志文章

相关文献

BLOOD文献大全
  • The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation.

    abstract::Transcriptional profiles of cultured primary human erythroid cells were examined to identify those genes involved in the control of erythroid growth during the terminal phase of maturation. Our in silico screening strategy indicated that a hypoxia-inducible proapoptotic member of the Bcl-2 gene family called Nix is ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3324

    authors: Aerbajinai W,Giattina M,Lee YT,Raffeld M,Miller JL

    更新日期:2003-07-15 00:00:00

  • Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

    abstract::Mutations in the nucleophosmin 1 (NPM1) gene are considered a founder event in the pathogenesis of acute myeloid leukemia (AML). To address the role of clonal evolution in relapsed NPM1-mutated (NPM1mut) AML, we applied high-resolution, genome-wide, single-nucleotide polymorphism array profiling to detect copy number ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-479188

    authors: Krönke J,Bullinger L,Teleanu V,Tschürtz F,Gaidzik VI,Kühn MW,Rücker FG,Holzmann K,Paschka P,Kapp-Schwörer S,Späth D,Kindler T,Schittenhelm M,Krauter J,Ganser A,Göhring G,Schlegelberger B,Schlenk RF,Döhner H,Döhner K

    更新日期:2013-07-04 00:00:00

  • Constitutive expression of GATA-1, EPOR, alpha-globin, and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia.

    abstract::Juvenile chronic myelocytic leukemia (JCML) is a rare disorder of early childhood. Characteristic of JCML are the progressive appearance of high levels of fetal hemoglobin (HbF), reflecting a true reversion to a fetal type of erythropoiesis, and the presence of colony-forming cells able to grow in vitro spontaneously ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Privitera E,Schirò R,Longoni D,Ronchi A,Rambaldi A,Bernasconi S,Ottolenghi S,Masera G,Biondi A

    更新日期:1995-07-01 00:00:00

  • Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.

    abstract::Endothelial cell prostacyclin (PGI2) inhibits platelet activation by raising platelet cyclic AMP. Previously, platelet activation was also shown to be blocked by plasmin formed by endothelium-derived tissue plasminogen activator (TPA). We have now studied interactions between PGI2 and plasmin in the control of platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schafer AI,Zavoico GB,Loscalzo J,Maas AK

    更新日期:1987-05-01 00:00:00

  • Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells.

    abstract::Interleukin (IL)-23 is a proinflammatory cytokine belonging to the IL-12 superfamily. The antitumor activity of IL-23 is controversial, and it is unknown whether or not the cytokine can act directly on tumor cells. The aim of this study was to investigate the potential direct antitumor activity of IL-23 in pediatric B...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-248245

    authors: Cocco C,Canale S,Frasson C,Di Carlo E,Ognio E,Ribatti D,Prigione I,Basso G,Airoldi I

    更新日期:2010-11-11 00:00:00

  • Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4.

    abstract::The stress-activated protein/c-Jun N-terminal kinases (SAPK/JNK) have been shown to be activated by pro-inflammatory cytokines, as well as physical and chemical stresses. We now show that a variety of hematopoietic growth factors, including Steel locus factor (SLF), granulocyte-macrophage colony-stimulating factor (GM...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Foltz IN,Schrader JW

    更新日期:1997-05-01 00:00:00

  • CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons.

    abstract::CD34+ cells devoid of detectable mature and immature T and B lymphocytes, expressing the CD2, CD10, and CD20 antigens, were isolated from marrows of three pairs of sex-mismatched, mixed lymphocyte culture (MLC) nonreactive, sibling baboons. Reciprocal transplants were performed between members of each pair, using the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Andrews RG,Bryant EM,Bartelmez SH,Muirhead DY,Knitter GH,Bensinger W,Strong DM,Bernstein ID

    更新日期:1992-10-01 00:00:00

  • Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.

    abstract::To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified tumor cells, including samples from patients with premalignant monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and extramedullary plasma cell (PC) tumors (ExPC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0833

    authors: Rasmussen T,Kuehl M,Lodahl M,Johnsen HE,Dahl IM

    更新日期:2005-01-01 00:00:00

  • Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia.

    abstract::Crystal formation by monoclonal immunoglobulins is a well-known but rare complication of B-cell neoplasia. We have designed an in vivo model of cryocrystalglobulinemia by grafting to mice hybridoma clones producing a pathogenic monoclonal immunogloblulin (Ig) G3kappa. One clone, 8A4, secreted a singular IgG3 that form...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rengers JU,Touchard G,Decourt C,Deret S,Michel H,Cogné M

    更新日期:2000-06-01 00:00:00

  • Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

    abstract::Twenty-six patients with progressive Hodgkin's disease after conventional chemotherapy received intensive chemoradiotherapy and autologous bone marrow transplantation (ABMT); 19 also received additional involved-field radiotherapy. Twenty-one patients [81%, 95% confidence intervals (CI) 61% to 94%] attained complete (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Phillips GL,Wolff SN,Herzig RH,Lazarus HM,Fay JW,Lin HS,Shina DC,Glasgow GP,Griffith RC,Lamb CW

    更新日期:1989-06-01 00:00:00

  • Retinoid signaling regulates primitive (yolk sac) hematopoiesis.

    abstract::It is known from nutritional studies that vitamin A is an important factor for normal hematopoiesis, though it has been difficult to define its precise role. The vitamin A-deficient (VAD) quail embryo provides an effective ligand "knockout" model for investigating the function of retinoids during development. The VAD ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.7.2379

    authors: Ghatpande S,Ghatpande A,Sher J,Zile MH,Evans T

    更新日期:2002-04-01 00:00:00

  • Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses.

    abstract::Little is known about the ontogeny of naturally occurring CD4(+)CD25(+) regulatory/suppressor T cells that play a major role in maintaining self-tolerance in mice and humans. In rodents, thymectomy on day 3 of life leads to multiple organ-specific autoimmune diseases that can be prevented by adoptive transfer of regul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-4051

    authors: Darrasse-Jèze G,Marodon G,Salomon BL,Catala M,Klatzmann D

    更新日期:2005-06-15 00:00:00

  • Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation.

    abstract::Activated protein C (APC) is inhibited by two major plasma inhibitors (PCIs). To find evidence for in vivo complexation of APC, immunoblotting studies were performed on plasmas of 85 patients with suspected disseminated intravascular coagulation (DIC). Samples from 62 of these patients contained 5% to 35% of protein C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Heeb MJ,Mosher D,Griffin JH

    更新日期:1989-02-01 00:00:00

  • A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT.

    abstract::To ascertain the genetic basis of a paroxysmal nocturnal hemoglobinuria (PNH) case without somatic mutations in PIGA, we performed deep next-generation sequencing on all exons of known genes of the glycosylphosphatidylinositol (GPI) anchor synthesis pathway. We identified a heterozygous germline splice site mutation i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-481499

    authors: Krawitz PM,Höchsmann B,Murakami Y,Teubner B,Krüger U,Klopocki E,Neitzel H,Hoellein A,Schneider C,Parkhomchuk D,Hecht J,Robinson PN,Mundlos S,Kinoshita T,Schrezenmeier H

    更新日期:2013-08-15 00:00:00

  • Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.

    abstract::Histone deacetylase (HDAC) enzymatic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM). Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM. In the present study, we investigated the preclinical activity of ACY-1215,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387365

    authors: Santo L,Hideshima T,Kung AL,Tseng JC,Tamang D,Yang M,Jarpe M,van Duzer JH,Mazitschek R,Ogier WC,Cirstea D,Rodig S,Eda H,Scullen T,Canavese M,Bradner J,Anderson KC,Jones SS,Raje N

    更新日期:2012-03-15 00:00:00

  • A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation.

    abstract::A20 is a stress response gene in endothelial cells (ECs). A20 serves a dual cytoprotective function, protecting from tumor necrosis factor (TNF)-mediated apoptosis and inhibiting inflammation via blockade of the transcription factor nuclear factor-kappaB (NF-kappaB). In this study, we evaluated the molecular basis of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0635

    authors: Daniel S,Arvelo MB,Patel VI,Longo CR,Shrikhande G,Shukri T,Mahiou J,Sun DW,Mottley C,Grey ST,Ferran C

    更新日期:2004-10-15 00:00:00

  • Safety and immunologic effects of IL-15 administration in nonhuman primates.

    abstract::The administration of cytokines that modulate endogenous or transferred T-cell immunity could improve current approaches to clinical immunotherapy. Interleukin-2 (IL-2) is used most commonly for this purpose, but causes systemic toxicity and preferentially drives the expansion of CD4(+)CD25(+)Foxp3(+) regulatory T cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-189266

    authors: Berger C,Berger M,Hackman RC,Gough M,Elliott C,Jensen MC,Riddell SR

    更新日期:2009-09-17 00:00:00

  • Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells.

    abstract::Leukemia inhibitory factor (LIF)/differentiation-inhibiting activity (DIA)/human interleukin for DA cells (HILDA) is a cytokine with biologic activities involving a variety of different types of target cells. Here we have tested LIF/DIA for possible effects on the growth and differentiation of normal human hematopoiet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Leary AG,Wong GG,Clark SC,Smith AG,Ogawa M

    更新日期:1990-05-15 00:00:00

  • Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro.

    abstract::Late committed progenitor cells of erythropoiesis, CFU-E (colony-forming unit--erythroid), were isolated from mouse spleens to near homogeneity by a three-step enrichment procedure. The procedure included a four-day pretreatment of bled mice with the antibiotic thiamphenicol, a recovery period of 3 1/2 days, followed ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nijhof W,Wierenga PK,Staal GE,Jansen G

    更新日期:1984-09-01 00:00:00

  • The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model.

    abstract::Current treatment strategies for chronic lymphocytic leukemia (CLL) involve a combination of conventional chemotherapeutics, monoclonal antibodies, and targeted signaling inhibitors. However, CLL remains largely incurable, with drug resistance and treatment relapse a common occurrence, leading to the search for novel ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-11-610329

    authors: Blunt MD,Carter MJ,Larrayoz M,Smith LD,Aguilar-Hernandez M,Cox KL,Tipton T,Reynolds M,Murphy S,Lemm E,Dias S,Duncombe A,Strefford JC,Johnson PW,Forconi F,Stevenson FK,Packham G,Cragg MS,Steele AJ

    更新日期:2015-06-25 00:00:00

  • Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.

    abstract::Arsenic trioxide (As₂O₃) is a highly effective treatment for patients with refractory/relapsed acute promyelocytic leukemia (APL), but resistance to As₂O₃ has recently been seen. In the present study, we report the findings that 2 of 15 patients with refractory/relapsed APL treated with As₂O₃ were clinically As₂O₃ res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-329433

    authors: Goto E,Tomita A,Hayakawa F,Atsumi A,Kiyoi H,Naoe T

    更新日期:2011-08-11 00:00:00

  • The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.

    abstract::Dendritic cell (DC) development is efficiently supported by Flt3-ligand or GM-CSF in vitro, and lymphoid-organ DC maintenance in vivo is critically dependent on Flt3-ligand. However, the relevance of GM-CSF for lymphoid-tissue DC maintenance and the importance of both cytokines for nonlymphoid organ DC homeostasis are...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-206318

    authors: Kingston D,Schmid MA,Onai N,Obata-Onai A,Baumjohann D,Manz MG

    更新日期:2009-07-23 00:00:00

  • Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

    abstract::We evaluated the efficacy of umbilical cord blood (UCB) in the setting of a nonmyeloablative regimen consisting of fludarabine (200 mg/m2), cyclophosphamide (50 mg/kg), and a single fraction of total body irradiation (200 cGy) with cyclosporine and mycophenolate mofetil for posttransplantation immunoprophylaxis. The t...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2007-04-067215

    authors: Brunstein CG,Barker JN,Weisdorf DJ,DeFor TE,Miller JS,Blazar BR,McGlave PB,Wagner JE

    更新日期:2007-10-15 00:00:00

  • Toll-like receptors and their ligands control mesenchymal stem cell functions.

    abstract::Mesenchymal stem cells (MSCs) are widespread in adult organisms and may be involved in tissue maintenance and repair as well as in the regulation of hematopoiesis and immunologic responses. Thus, it is important to discover the factors controlling MSC renewal and differentiation. Here we report that adult MSCs express...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-06-028704

    authors: Pevsner-Fischer M,Morad V,Cohen-Sfady M,Rousso-Noori L,Zanin-Zhorov A,Cohen S,Cohen IR,Zipori D

    更新日期:2007-02-15 00:00:00

  • CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes.

    abstract::Evidence is presented showing that a protein tyrosine phosphatase different from CD45 is present on the membrane of human hematopoietic cells. The molecule recognized by the monoclonal antibody 143-41, which has been classified as CD148 in the VI International Workshop on Leukocyte Differentiation Antigens, was immuno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de la Fuente-García MA,Nicolás JM,Freed JH,Palou E,Thomas AP,Vilella R,Vives J,Gayá A

    更新日期:1998-04-15 00:00:00

  • Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

    abstract::Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm with variable clinical course. To predict the clinical outcome, we previously developed a CMML-specific prognostic scoring system (CPSS) based on clinical parameters and cytogenetics. In this work, we tested the hypothesis that acc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-05-714030

    authors: Elena C,Gallì A,Such E,Meggendorfer M,Germing U,Rizzo E,Cervera J,Molteni E,Fasan A,Schuler E,Ambaglio I,Lopez-Pavia M,Zibellini S,Kuendgen A,Travaglino E,Sancho-Tello R,Catricalà S,Vicente AI,Haferlach T,Haferlach

    更新日期:2016-09-08 00:00:00

  • Intensive leukapheresis as initial therapy for chronic granulocytic leukemia.

    abstract::Intensive leukapheresis has been used as the initial treatment of chronic granulocytic leukemia (CGL) in six patients. The number of leukaphereses ranged from 3 in 7 days to 13 in 39 days (mean, 8 in 22 days). The procedures were well tolerated, and in all patients there was improvement in hematologic values, in most ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lowenthal RM,Buskard NA,Goldman JM,Spiers AS,Bergier N,Graubner M,Galton DA

    更新日期:1975-12-01 00:00:00

  • Concomitant inactivation of Rb and E2f8 in hematopoietic stem cells synergizes to induce severe anemia.

    abstract::The retinoblastoma (Rb) tumor suppressor plays important roles in regulating hematopoiesis, particularly erythropoiesis. In an effort to understand whether Rb function can be mediated by E2F transcription factors in a BM-derived hematopoietic system in mice, we uncovered a functional synergy between Rb and E2F8 to pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-388231

    authors: Hu T,Ghazaryan S,Sy C,Wiedmeyer C,Chang V,Wu L

    更新日期:2012-05-10 00:00:00

  • Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.

    abstract::Diffuse large B-cell lymphoma (DLBCL) consists of at least 2 phenotypic subtypes; that is, the germinal center B-cell-like (GCB-DLBCL) and the activated B-cell-like (ABC-DLBCL) groups. It has been shown that GCB-DLBCL responds favorably to chemotherapy and expresses high levels of BCL6, a transcription repressor known...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-087734

    authors: Ding BB,Yu JJ,Yu RY,Mendez LM,Shaknovich R,Zhang Y,Cattoretti G,Ye BH

    更新日期:2008-02-01 00:00:00

  • Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization.

    abstract::Many current experimental results show the necessity of new conceptual approaches to understand hematopoietic stem cell organization. Recently, we proposed a novel theoretical concept and a corresponding quantitative model based on microenvironment-dependent stem cell plasticity. The objective of our present work is t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0282

    authors: Roeder I,Kamminga LM,Braesel K,Dontje B,de Haan G,Loeffler M

    更新日期:2005-01-15 00:00:00